Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease.

D. M. Harris; A. Fisher; A. J. Harkin; Anthony E. Bolton; Aideen Sullivan; Yvonne Nolan

Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease.

D. M. Harris
, A. Fisher
, A. J. Harkin
, Anthony E. Bolton
, Aideen Sullivan
, Yvonne Nolan

School of Medicine

Vasogen Ireland Ltd.
University College Cork
University of Galway
Trinity College Dublin
Institute for Neuroscience
Vasogen Ireland Ltd.
Vasogen
Vasogen Ireland Limited

Research output: Contribution to conference › Poster

Original language	English (Ireland)
Publication status	Published - 2005

Cite this

@conference{4b84f4196ed54ebb943a029256caa121,

title = "Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson{\textquoteright}s disease.",

author = "Harris, \{D. M.\} and A. Fisher and Harkin, \{A. J.\} and Bolton, \{Anthony E.\} and Aideen Sullivan and Yvonne Nolan",

note = "[Poster Presentation], Royal Irish Academy of Medicine, Dublin, Ireland , 05-JAN-05 - 06-JAN-05.",

year = "2005",

language = "English (Ireland)",

}

TY - CONF

T1 - Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease.

AU - Harris, D. M.

AU - Fisher, A.

AU - Harkin, A. J.

AU - Bolton, Anthony E.

AU - Sullivan, Aideen

AU - Nolan, Yvonne

N1 - [Poster Presentation], Royal Irish Academy of Medicine, Dublin, Ireland , 05-JAN-05 - 06-JAN-05.

PY - 2005

Y1 - 2005

M3 - Poster

ER -